Bringing Safe and Standardized Cell Therapies to Industrialized Processing for Burns and Wounds

Bringing Safe and Standardized Cell Therapies to Industrialized Processing for Burns and Wounds

Cultured primary progenitor cell types are worthy therapeutic candidates for regenerative medicine. Clinical translation, industrial transposition, and commercial implementation of products based on such cell sources are mainly hindered by economic or technical barriers and stringent regulatory requ...

Full description

Bibliographic Details
Main Authors: Alexis Laurent, Poyin Lin, Corinne Scaletta, Nathalie Hirt-Burri, Murielle Michetti, Anthony S. de Buys Roessingh, Wassim Raffoul, Bin-Ru She, Lee Ann Applegate
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-06-01
Series:Frontiers in Bioengineering and Biotechnology
Subjects:
cell therapy
clinical cell banking
progenitor cells
fibroblasts
GMP manufacturing
burns
Online Access:https://www.frontiersin.org/article/10.3389/fbioe.2020.00581/full

Internet

https://www.frontiersin.org/article/10.3389/fbioe.2020.00581/full

Similar Items